Bacterial vaginosis
Bacterial vaginosis is an abnormal vaginal condition that is characterized by vaginal discharge and results from an overgrowth of atypical bacteria in the vagina. It is not a true bacterial infection but rather an imbalance of the bacteria that are normally present in the vagina. Usually treatment is with an antibiotic, such as clindamycin or metronidazole. BV is the most common vaginal infection in women of reproductive age. In the United States about 30% of women between the ages of 14 and 49 are affected. BV is linked to an imbalance of “good” and “harmful” bacteria that are normally found in a woman’s vagina. Bacterial vaginosis results from overgrowth of one of several bacteria naturally found in your vagina. Usually, "good" bacteria (lactobacilli) outnumber "bad" bacteria (anaerobes). But if there are too many anaerobic bacteria, they upset the natural balance of microorganisms in your vagina and cause bacterial vaginosis. BV is a polymicrobial clinical syndrome resulting from replacement of the normal hydrogen peroxide producing Lactobacillus sp. in the vagina with high concentrations of anaerobic bacteria (e.g., Prevotella sp. and Mobiluncus sp.), G. vaginalis, Ureaplasma, Mycoplasma, and numerous fastidious or uncultivated anaerobes. Some women experience transient vaginal microbial changes, whereas others experience them for longer intervals of time.
Related Conference of Bacterial vaginosis
10th International Congress on Trauma, Critical Care and Emergency Medicine
19th International Conference on Virology, Emerging Diseases & vaccines
9th International Conference on Molecular Medicine and Diagnostics
8th International Conference on Microbiome, Probiotics & Gut Nutrition
7th International Conference on Antimicrobial and Antibacterial Agents
7th International Conference on Clinical Microbiology, Virology and Infectious Diseases
Bacterial vaginosis Conference Speakers
Recommended Sessions
- Bacterial Genomics
- Advances in Antimicrobials, Vaccines and therapeutics
- Alternatives to Antibiotics
- Antibiotic Prophylaxis
- Antibiotic Regulatory Affairs
- Antibiotic Resistance
- Antibiotic sensitivity
- Antibiotics in Chronic Respiratory Diseases
- Antibiotics in Oncology
- Antibiotics in Our Food System
- Antibiotics: Market Analysis & Business Opportunities
- Anticancer Antibiotics
- Bacterial Biochemistry
- Bacterial Clinical Studies
- Bacterial Ecology
- Bacterial Identification Methods
- Bacterial infections
- Bacterial pathogenesis
- Bacterial physiology
- Bacterial Vaccine
- Bacterial vaginosis
- Bacteriology in Public Health
- Bacteriology of dental infections
- Clinical Bacteriology
- Clinical Trials of Antibiotics
- Emerging Infectious Diseases
- Food Poisoning Bacteria
- Medical Bacteriology and Immunology
- Medical Use of Antibiotics
- Microbial Pathogenesis
- MRSA
- Multi Pathogen Infections
- Naturopathy for Bacterial Infections
- Next-Generation Antibiotics
- Pharmacology of antibiotics
- Plant Bacteriology
- Toxicity of antibiotics
- Urinary Tract Infection (UTI)
Related Journals
Are you interested in
- 16S sequencing & Analysis - Microbiome 2024 (UK)
- Agriculture Microbiology - Beneficial Microbes 2024 (Ireland)
- Animals in a bacterial world, a new imperative for the life sciences - Microbiome 2024 (UK)
- Antimicrobial Use in Veterinary Medicine - Antimicrobial Congress 2024 (Czech Republic)
- Antimicrobials - Antimicrobial Congress 2024 (Czech Republic)
- Antiviral Therapies and Drug Development - Antimicrobial Congress 2024 (Czech Republic)
- Arbuscular Mycorrhizal Fungi [AMF] - Microbiome 2024 (UK)
- Beneficial Microbes in the environment - Beneficial Microbes 2024 (Ireland)
- Benefits Of Bio stimulants - Microbiome 2024 (UK)
- Bioinformatics for Microbiome - Microbiome 2024 (UK)
- Biological Need of Trauma - TRAUMA 2024 (Netherlands)
- Biostimulants and Biocontrol strategies - Microbiome 2024 (UK)
- Blunt Trauma - TRAUMA 2024 (Netherlands)
- Clinical and Neuro Virology - Virology-2024 (Canada)
- Combination Therapy for Antimicrobial Resistance - Antimicrobial Congress 2024 (Czech Republic)
- Corona Virus - Virology-2024 (Canada)
- Critical Care in Trauma - TRAUMA 2024 (Netherlands)
- Delirium in Critical Care - TRAUMA 2024 (Netherlands)
- Drug-Resistant Bacteria: Challenges and Solutions - Antimicrobial Congress 2024 (Czech Republic)
- Ecology and Evolution of Microbe-Host Interactions - Beneficial Microbes 2024 (Ireland)
- Elderly Trauma and Critical Care - TRAUMA 2024 (Netherlands)
- Engineering Beneficial Microbes - Beneficial Microbes 2024 (Ireland)
- Evolution in Emergency Medicine Practices - TRAUMA 2024 (Netherlands)
- General Virology - Virology-2024 (Canada)
- Gut Micro biota - Microbiome 2024 (UK)
- Harnessing phyto Microbiome signaling for Microbiome engineering - Microbiome 2024 (UK)
- Harnessing phyto Microbiome signaling for Microbiome engineering - Microbiome 2024 (UK)
- HIV/AIDS and Sexually Transmitted Infections - Virology-2024 (Canada)
- Horticulture Hydroponics - Microbiome 2024 (UK)
- Host-Microbe Biology (HMB) - Microbiome 2024 (UK)
- Human Micro biota - Microbiome 2024 (UK)
- Immunization and Immunotherapeutics - Virology-2024 (Canada)
- Immunobiotics - Beneficial Microbes 2024 (Ireland)
- Influenza and other Respiratory Diseases - Virology-2024 (Canada)
- Intensive Care in Trauma - TRAUMA 2024 (Netherlands)
- Interplay between diet, gut micro biota, epigenetic events, and colorectal cancer - Microbiome 2024 (UK)
- Marine Microbiology - Beneficial Microbes 2024 (Ireland)
- Mechanisms of Antibiotic Resistance - Antimicrobial Congress 2024 (Czech Republic)
- Micro biota in early life shapes the immune system - Microbiome 2024 (UK)
- Microbial Infections - Virology-2024 (Canada)
- Microbiome - Beneficial Microbes 2024 (Ireland)
- Microbiome - Microbiome 2024 (UK)
- Microbiome as a human organ - Microbiome 2024 (UK)
- Microbiome: Science comes to life - Microbiome 2024 (UK)
- Modulation of Micro biota - Microbiome 2024 (UK)
- Nanotechnology in Antimicrobial Drug Delivery - Antimicrobial Congress 2024 (Czech Republic)
- New and Endogenous Retroviruses - Virology-2024 (Canada)
- New Technology in Trauma - TRAUMA 2024 (Netherlands)
- Novel Antibiotics and Antimicrobial Agents - Antimicrobial Congress 2024 (Czech Republic)
- Novel Antiviral Therapies - Virology-2024 (Canada)
- Novel Vaccine Delivery Methods - Virology-2024 (Canada)
- Obstetric Trauma - TRAUMA 2024 (Netherlands)
- Paediatric Trauma - TRAUMA 2024 (Netherlands)
- Pathogenic Microbes in Immunology and Microbiology - Beneficial Microbes 2024 (Ireland)
- Pathogenic Microbes in Medicine and Dentistry - Beneficial Microbes 2024 (Ireland)
- Pediatric Microbiome [Vaginal Delivery Versus C-Section] - Microbiome 2024 (UK)
- Pharmacogenomics - Microbiome 2024 (UK)
- Pharmacokinetics and Pharmacodynamics of Antimicrobials - Antimicrobial Congress 2024 (Czech Republic)
- Plant Beneficial Microbes - Microbiome 2024 (UK)
- Plant Conditioners [Biostimulants] - Microbiome 2024 (UK)
- Prebiotics and Probiotics - Microbiome 2024 (UK)
- Probiotics & Prebiotics - Beneficial Microbes 2024 (Ireland)
- Psychological Trauma - TRAUMA 2024 (Netherlands)
- Role of microbial communities in the pathogenesis of periodontal diseases and caries (Oral Microbiome) - Microbiome 2024 (UK)
- Signaling in the phytoMicrobiome - Microbiome 2024 (UK)
- Skincare products with probiotics worth the hype - Microbiome 2024 (UK)
- Soil biological management - Beneficial Microbes 2024 (Ireland)
- Strategies for Fungal Infections - Antimicrobial Congress 2024 (Czech Republic)
- Structural and Molecular virology - Virology-2024 (Canada)
- The Dynamic Microbiome - Microbiome 2024 (UK)
- The globalization of cannabis cultivation- A Growing Challenge - Microbiome 2024 (UK)
- The Microbiome as a Therapeutic Target for Metabolic Diseases - Microbiome 2024 (UK)
- The role of the Microbiome in cancer development and therapy - Microbiome 2024 (UK)
- The Skin Microbiome - Microbiome 2024 (UK)
- Transmission of Viruses - Virology-2024 (Canada)
- Transplant-Associated Viral Infections - Virology-2024 (Canada)
- Trauma & Critical Care Nursing - TRAUMA 2024 (Netherlands)
- Trauma Emergency Medicine - TRAUMA 2024 (Netherlands)
- Trauma in Nursing & Midwifery - TRAUMA 2024 (Netherlands)
- Trauma Therapy - TRAUMA 2024 (Netherlands)
- Trauma-An International Perspective - TRAUMA 2024 (Netherlands)
- Trauma-Mass Casualties Incidents - TRAUMA 2024 (Netherlands)
- Vaccines against Emerging Diseases (Ebola/Zika/Dengue/Chik) - Virology-2024 (Canada)
- Vaccines and Immunotherapies - Antimicrobial Congress 2024 (Czech Republic)
- Vaccines and the Microbiome - Virology-2024 (Canada)
- Veterinary virology - Virology-2024 (Canada)
- Viral Genetics, Evolution and Dynamics - Virology-2024 (Canada)
- Viral Immunology and Immunopathology - Virology-2024 (Canada)
- Viral Oncology - Virology-2024 (Canada)
- Viral Pathogenesis - Virology-2024 (Canada)